Parkinson's disease is due to a degeneration predominantly of dopaminergic neurons, Alzheimer's of cholinergic neurons while other aminergic neurotransmitter systems are involved to a lesser degree. It is discussed controversially in how far the CSF concentrations of amines/metabolites might contribute to differential diagnosis (Gibson et al., 1985).CSF and serum were obtained from 43 patients suffering from neurodegenerative diseases (Fig. 1). Amines and metabolites were determined by HPLC-EC. Neuropsychiatric impairments as well as brain atrophy and generalized abnormalities of the EEG were rated from '0' to '3' (severe). Patients were split in subgroups according to the presence/absence of psychotropic medication during the week before lumbar puncture. Data were analysed by linear correlations. ANOVA and t-tests (threshold: p < 0.05).Previous findings of differences in CSF amines/metabolites between Alzheimer's and Parkinson's disease could not be replicated, possibly due to preceding drug treatment. The only significant laboratory results were an increase of CSF 5-HIAA in Alzheimer patients
409-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.